Morgan Stanley Maintains Equal-Weight on Healthpeak Properties, Lowers Price Target to $26
Morgan Stanley analyst Richard Hill maintains Healthpeak Properties (NYSE:PEAK) with a Equal-Weight and lowers the price target from $32.5 to $26.
Citigroup Upgrades Healthpeak Properties to Buy, Lowers Price Target to $31
Citigroup analyst Nicholas Joseph upgrades Healthpeak Properties (NYSE:PEAK) from Neutral to Buy and lowers the price target from $33 to $31.
Stocks That Hit 52-Week Lows On Thursday
During the Thursday's session, 100 stocks hit new 52-week lows.
Morgan Stanley Maintains Equal-Weight on Healthpeak Properties, Lowers Price Target to $32.5
Morgan Stanley analyst Richard Hill maintains Healthpeak Properties (NYSE:PEAK) with a Equal-Weight and lowers the price target from $34.5 to $32.5.
B of A Securities Downgrades Healthpeak Properties to Neutral, Announces $32 Price Target
B of A Securities analyst Joshua Dennerlein downgrades Healthpeak Properties (NYSE:PEAK) from Buy to Neutral and announces $32 price target.
Thursday Is Your Last Chance To Buy Healthpeak Properties Before The Dividend Payout
Thursday marks the last chance for investors to receive the next dividend payout from Healthpeak Properties (NYSE:PEAK).